Lentigen and Dharmacon Pen shRNA Development Deal
Lentigen and Dharmacon Pen shRNA Development Deal
August 30, 2006
GenomeWeb
NEW YORK (GenomeWeb News) ? Lentigen and Dharmacon today said they plan to develop and manufacture lentiviral expression reagents to deliver short hairpin RNA expression vectors into cells using RNA interference-mediated gene silencing.
As part of the alliance Dharmacon will design reagents combined with Lentigen's high-titer LentiMax vector system to develop the lentiviral particles. Terms of the deal call for Lentigen to manufacture and Dharmacon to sell the resulting products.
Financial details were not disclosed.
